Author: Charles Bennett
Charles Bennett
Charles Bennett is a prominent analyst and commentator with extensive expertise in the smoking and tobacco industry. With over a decade of experience, Charles has garnered a deep understanding of the regulatory, economic, and cultural aspects of tobacco products. His insights into market trends, legislative changes, and public health impacts make him a respected voice in discussions about the future of smoking and tobacco use.
As the new year approaches and more Britons than ever find themselves hooked on vaping, a landmark study has identified two potentially effective methods for quitting: the anti-smoking pill varenicline and text message-based support programs. With an estimated one in ten UK adults now vaping, and around 8% of adult vapers having never smoked before, finding effective cessation tools has become increasingly important. Varenicline and Text Support Stand Out in Review A review of nine trials involving more than 5,000 participants, conducted by academics from the US and UK, found that the tablet varenicline (known as Champix) and text message-based…